Edge, Fog, and Cloud Against Disease: The Potential of High-Performance Cloud Computing for Pharma Drug Discovery
- PMID: 37702940
- DOI: 10.1007/978-1-0716-3449-3_8
Edge, Fog, and Cloud Against Disease: The Potential of High-Performance Cloud Computing for Pharma Drug Discovery
Abstract
The high-performance computing (HPC) platform for large-scale drug discovery simulation demands significant investment in speciality hardware, maintenance, resource management, and running costs. The rapid growth in computing hardware has made it possible to provide cost-effective, robust, secure, and scalable alternatives to the on-premise (on-prem) HPC via Cloud, Fog, and Edge computing. It has enabled recent state-of-the-art machine learning (ML) and artificial intelligence (AI)-based tools for drug discovery, such as BERT, BARD, AlphaFold2, and GPT. This chapter attempts to overview types of software architectures for developing scientific software or application with deployment agnostic (on-prem to cloud and hybrid) use cases. Furthermore, the chapter aims to outline how the innovation is disrupting the orthodox mindset of monolithic software running on on-prem HPC and provide the paradigm shift landscape to microservices driven application programming (API) and message parsing interface (MPI)-based scientific computing across the distributed, high-available infrastructure. This is coupled with agile DevOps, and good coding practices, low code and no-code application development frameworks for cost-efficient, secure, automated, and robust scientific application life cycle management.
Keywords: Cloud computing; Cloud-batch computing; Containerization; DevOps; Docker; Edge computing; Fog computing; Grid and cluster computing; High-performance computing (HPC); Podman; Scalable computing; Scientific DevOps; Scientific applications; Singularity; Swarm and Kubernetes for Scientific computing applications.
© 2024. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
The machine learning life cycle and the cloud: implications for drug discovery.Expert Opin Drug Discov. 2021 Sep;16(9):1071-1079. doi: 10.1080/17460441.2021.1932812. Epub 2021 May 31. Expert Opin Drug Discov. 2021. PMID: 34057379
-
RAPPORT: running scientific high-performance computing applications on the cloud.Philos Trans A Math Phys Eng Sci. 2012 Dec 10;371(1983):20120073. doi: 10.1098/rsta.2012.0073. Print 2013 Jan 28. Philos Trans A Math Phys Eng Sci. 2012. PMID: 23230157
-
Quality of Service Aware Orchestration for Cloud-Edge Continuum Applications.Sensors (Basel). 2022 Feb 23;22(5):1755. doi: 10.3390/s22051755. Sensors (Basel). 2022. PMID: 35270901 Free PMC article.
-
Smart Containers Schedulers for Microservices Provision in Cloud-Fog-IoT Networks. Challenges and Opportunities.Sensors (Basel). 2020 Mar 19;20(6):1714. doi: 10.3390/s20061714. Sensors (Basel). 2020. PMID: 32204390 Free PMC article. Review.
-
Resource Management Techniques for Cloud/Fog and Edge Computing: An Evaluation Framework and Classification.Sensors (Basel). 2021 Mar 5;21(5):1832. doi: 10.3390/s21051832. Sensors (Basel). 2021. PMID: 33808037 Free PMC article. Review.
References
-
- Saharan VA, Banerjee S, Penuli S, Dobhal S (2022) History and present scenario of computers in pharmaceutical research and development. Comput Aided Pharm Drug Deliv 1–38. https://doi.org/10.1007/978-981-16-5180-9_1
-
- Schaller RR (1997) Moore’s law: past, present, and future. IEEE Spectr 34(52–55):57. https://doi.org/10.1109/6.591665 - DOI
-
- Grannan A, Sood K, Norris B, Dubey A (2020) Understanding the landscape of scientific software used on high-performance computing platforms. Int J High Perform Comput Appl 34:465–477. https://doi.org/10.1177/1094342019899451/ - DOI
-
- Jamkhande PG, Ghante MH, Ajgunde BR (2017) Software based approaches for drug designing and development: a systematic review on commonly used software and its applications. Bull Fac Pharm Cairo Univ 55:203–210. https://doi.org/10.1016/J.BFOPCU.2017.10.001 - DOI
-
- Badwan BA, Liaropoulos G, Kyrodimos E et al (2023) Machine learning approaches to predict drug efficacy and toxicity in oncology. Cell Rep Methods 3:100143. https://doi.org/10.1016/J.CRMETH.2023.100413 - DOI
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources